What is LEVULANHCP.com?
LEVULANHCP.com is a specialized entity focused on dermatological care, particularly known for its LEVULAN KERASTICK treatment. This therapeutic solution targets minimally to moderately thick actinic keratosis, employing a combination of aminolevulinic acid HCl and BLU-U light therapy. The company directs its innovative offerings towards healthcare professionals seeking advanced treatment modalities for actinic keratosis patients. Their product suite includes comprehensive prescribing information and detailed usage guidelines, positioning LEVULANHCP.com as a provider of sophisticated solutions within the dermatology sector.
How much funding has LEVULANHCP.com raised?
LEVULANHCP.com has raised a total of $24.8M across 1 funding round:
Private Equity
$24.8M
Private Equity (2004): $24.8M, investors not publicly disclosed
What's next for LEVULANHCP.com?
The substantial enterprise-level funding and recent strategic investment indicate a strong foundation for LEVULANHCP.com's continued development and market penetration. This capital infusion is likely to fuel further research and development into novel dermatological treatments, enhance manufacturing capabilities, and expand its reach to a broader base of healthcare providers. The company's focus on evidence-based treatments and professional targeting suggests a strategic approach to scaling its operations and solidifying its reputation as a leader in actinic keratosis management.
See full LEVULANHCP.com company page
